SIRT1 and urinary bladder cancer: Ping Tan et al. [71]demonstrated that inhibition of the SIRT1-HIF axis significantly slowed the growth of bladder cancer in mice and humans through organoid technology and identifying SRT1720 as a new therapy for bladder cancer.